DISRUPTIVE PHARMA pioneers pharmaceutical innovation through Pharma-MMC. Leveraging this proprietary platform, they craft novel drug products by combining approved APIs, enhancing absorption, enabling challenging drugs, and creating therapeutically superior formulations.DISRUPTIVE PHARMAdisruptivepharma.comEVAXION BIOTECH pioneers AI-immunologyTM, utilizing proprietary AI tech and drug development expertise to simulate the human immune system. Focused on novel immunotherapies for cancers, bacterial diseases, and viral infections, they are advancing EVX-01 and EVX-02 in clinical trials for diverse cancer treatments.EVAXION BIOTECHevaxion-biotech.comRECEPTOR AI specializes in precision therapeutics, prioritizing selectivity and protein-protein interaction (PPI) targeting. Their in-house hybrid intelligence drug discovery platform designs small molecules for orthosteric, allosteric, and cryptic binding sites, transforming peptides into oral peptidomimetic molecules for enhanced biological activity and superior therapeutic outcomes.RECEPTOR AIreceptor.aiRejuvenate Biomed is a clinical-stage entity, focuses on therapies to forestall age-related diseases. Privately held, they develop safe proprietary combination drugs fostering lifelong health. Leveraging platform technologies, they identify compounds impacting aging, discovering novel drugs to potentially delay multiple age-related diseases, confirmed via preclinical and clinical studies.Rejuvenate Biomedrejuvenatebiomed.coTOP 10DRUG DISCOVERYAND DEVELOPMENTSOLUTIONS PROVIDERS IN EUROPE - 2023
< Page 9 | Page 11 >